Calithera Biosciences (CALA) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free CALA Stock Alerts $0.02 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)April 26, 2024 | msn.comPrimecap Management Portfolio Exposed: Top Holdings RevealedFebruary 24, 2024 | uk.investing.comArcus Biosciences Inc (RCUS)August 12, 2023 | npr.orgChristina CalaJune 29, 2023 | seekingalpha.comCalithera Biosciences cancels special meeting due to lack of quorumJune 1, 2023 | finance.yahoo.comCALA - Calithera Biosciences, Inc.May 20, 2023 | finanznachrichten.deCalithera Biosciences, Inc.: Calithera Biosciences Announces Update on Complete Liquidation and DissolutionMay 19, 2023 | travel.usnews.comCala MarioluMay 19, 2023 | seekingalpha.comCalithera Biosciences plans special meeting to seek approval for liquidation and dissolution planMay 19, 2023 | finance.yahoo.comCalithera Biosciences Announces Update on Complete Liquidation and DissolutionMay 13, 2023 | travel.usnews.comCala LlombardsMay 12, 2023 | investing.comCalithera Biosciences Inc (CALA) Earnings Dates & ReportsJanuary 11, 2023 | marketwatch.comCalithera Biosciences Shares Plummet on Liquidation Plans >CALAJanuary 11, 2023 | marketwatch.comCalithera Biosciences to Liquidate >CALAJanuary 10, 2023 | finance.yahoo.comBiotech company Calithera plans its own death. Will others follow?January 9, 2023 | finanznachrichten.deCalithera Biosciences, Inc.: Calithera Biosciences Announces Board Approval of Complete Liquidation and DissolutionJanuary 9, 2023 | markets.businessinsider.comCalithera Biosciences Board Of Directors Determine Dissolution Of CompanyJanuary 9, 2023 | finance.yahoo.comCalithera Biosciences Stock Nosedives On Complete Liquidation, DissolutionJanuary 9, 2023 | finance.yahoo.comCalithera Biosciences Announces Board Approval of Complete Liquidation and DissolutionJanuary 9, 2023 | marketbeat.comTrading was temporarily halted for "CALA" at 07:01 AM with a stated reason of "News pending."November 15, 2022 | finanznachrichten.deCalithera Biosciences, Inc.: Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business UpdateNovember 15, 2022 | seekingalpha.comCalithera Biosciences, Inc. (CALA) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comCalithera Biosciences Reports Third Quarter 2022 Financial Results and Business UpdateNovember 8, 2022 | finance.yahoo.comCalithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022October 3, 2022 | marketwatch.comCalithera Biosciences Gets FDA Fast Track For Lung Cancer DrugOctober 3, 2022 | nasdaq.comCalithera Gets FDA Fast Track Designation For Sapanisertib For Squamous Lung Cancer TreatmentOctober 3, 2022 | finance.yahoo.comCalithera Receives FDA Fast Track Designation for Sapanisertib for the Treatment of NRF2-mutated Squamous Lung CancerOctober 3, 2022 | finance.yahoo.comCalithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidateOctober 1, 2022 | seekingalpha.comCALA Calithera Biosciences, Inc.September 21, 2022 | reuters.comCalithera Biosciences IncSeptember 17, 2022 | finance.yahoo.com3 Penny Stocks With Surprisingly Superior FundamentalsSeptember 6, 2022 | finance.yahoo.comCalithera to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceAugust 16, 2022 | finance.yahoo.comCompanies Like Calithera Biosciences (NASDAQ:CALA) Could Be Quite RiskyAugust 16, 2022 | finance.yahoo.comCalithera Biosciences Reports Second Quarter 2022 Financial Results and Recent HighlightsAugust 16, 2022 | seekingalpha.comCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q2 2022 Results - Earnings Call TranscriptAugust 12, 2022 | msn.comEarnings Preview For Calithera BiosciencesAugust 8, 2022 | finance.yahoo.comCalithera Biosciences to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022July 13, 2022 | apnews.comCalithera Biosciences Shares Progress in Sapanisertib and Mivavotinib Clinical Programs at Upcoming Lung Cancer and Lymphoma ConferencesJuly 13, 2022 | finance.yahoo.comCalithera Biosciences Shares Progress in Sapanisertib and Mivavotinib Clinical Programs at Upcoming Lung Cancer and Lymphoma ConferencesJuly 6, 2022 | tmcnet.comCalithera Biosciences Announces First Patient Enrolled in PhaseJuly 6, 2022 | finance.yahoo.comCalithera Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of Sapanisertib in Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung CancerJuly 5, 2022 | finance.yahoo.comWhat is a Reverse Stock Split and How Does it Work?June 23, 2022 | benzinga.comCalithera Commences Mid-Stage Study Of DLBCL CandidateJune 23, 2022 | finance.yahoo.comCalithera Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of Mivavotinib in Relapsed/Refractory non-GCB (ABC) Diffuse Large B-Cell LymphomaJune 15, 2022 | finanznachrichten.deCalithera Biosciences, Inc.: Calithera Biosciences Announces 1-for-20 Reverse Stock SplitJune 14, 2022 | seekingalpha.comCalithera Biosciences announces 1-for-20 reverse stock split to regain listing complianceJune 14, 2022 | finance.yahoo.comCalithera Biosciences Announces 1-for-20 Reverse Stock SplitMay 27, 2022 | finance.yahoo.comAfter a record-breaking decade, biotech is discovering what hard times feel likeMay 17, 2022 | finance.yahoo.comCalithera to Present at the H.C. Wainwright Global Investment ConferenceMay 11, 2022 | seekingalpha.comCalithera Biosciences stock slips after PT cut at Ladenburg Get Calithera Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. CALA Media Mentions By Week CALA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CALA News Sentiment▼0.000.55▲Average Medical News Sentiment CALA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CALA Articles This Week▼00▲CALA Articles Average Week Get Calithera Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STAB News Today AMPE News Today ATHX News Today BRSH News Today PKBO News Today SMFL News Today CNTX News Today GRFS News Today LVTX News Today MYNZ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CALA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calithera Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
